Skip to main content
SpringerLink
Log in

Immunotherapy in allergic respiratory diseases

  • Immunomodulation In Lung Diseases
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Much more work is needed to specify the correct indications for immunotherapy in respiratory allergic diseases.

Immunotherapy with pollen and mite extracts has shown some clinical efficacy versus placebo in controlled studies in allergic rhinitis and/or asthma. However, controlled studies comparing the cost, the risk factors and the efficacy of immunotherapy versus treatment with antihistaminic drugs, bronchodilatators and topical steroids are needed.

Additional studies are needed to established the place of immunotherapy in animal danders and mould allergy. In any case, before initiating immunotherapy in respiratory allergy the following questions must be answered: is there sufficient evidence of a close relationship between symptoms and allergen exposure? is it possible to achieve efficient allergen avoidance? is simple drug treatment not sufficient? is there evidence in the literature of effectiveness of IT for this allergen? is the patient able to comply with a long and constraining treatment?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Noon L (1911) Prophylactic inoculation against hay fever. Lancet i:1572–1573

    Article  Google Scholar 

  2. Creticos PS, Norman PS (1987) Immunotherapy with allergens. JAMA 258:2874–2880

    Article  PubMed  CAS  Google Scholar 

  3. Gurka G, Rocklin R (1988) Immunologic responses during allergen-specific immunotherapy for respiratory allergy. Ann Allergy 61:239–243

    PubMed  CAS  Google Scholar 

  4. Platts-Mills TAE, Hayden ML, Chapman MD, Wilkins SR (1987) Seasonal variation in dust mite and grass-pollen allergens in dust from the houses of patients with asthma. J Allergy Clin Immunol 79:781–791

    Article  PubMed  CAS  Google Scholar 

  5. Platts-Mills TAE (1989) Dust mite allergens and asthma—a worldwide problem. J Allergy Clin Immunol 83:416–427

    Article  Google Scholar 

  6. Price JF, Warner JO, Hey EN, Turner MW, Soothill JF (1984) A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects. Clin Allergy 14:209–219

    Article  PubMed  CAS  Google Scholar 

  7. D’Souza MF, Pepys J, Wells ID, Tai E, Palmer F, Overell BG, McGrath IT, Megson M (1973) Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects. Clin Allergy 3:177–193

    Article  PubMed  Google Scholar 

  8. Gabriel SM, Allan WGL, Hill LE, Nunn AJ (1977) Study of prolonged hyposensitization with D. pteronyssinus extract in allergic rhinitis. Clin Allergy 7:325–336

    Article  Google Scholar 

  9. Warner JD, Price JF, Soothill JF, Hey EH (1978) Controlled trial of hyposensitization to dermatophagoides pteronyssinus in children with athma. Lancet ii:912–915

    Article  Google Scholar 

  10. Blainey AD, Phillips MJ, Ollier S, Davies RJ (1984) Hyposensitization with a tyrosine adsorbed extract of Dermatophagoides pteronyssinus in adults with perennial rhinitis. A controlled clinical trial. Allergy 39:521–528

    Article  PubMed  CAS  Google Scholar 

  11. Scadding GK, Brostoff J (1986) Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 16:483–491

    Article  PubMed  CAS  Google Scholar 

  12. Ewan PW, Alexander MM, Snape C, Ind PW, Agrell B, Dreborg S (1988) Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite. Clin Allergy 18:501–508

    Article  PubMed  CAS  Google Scholar 

  13. Corrado OJ, Pastorello E, Ollier S, Cresswell L, Zanussi C, Ortolani C, Incorvaia A, Fugassa A, Lovely JR, Harris RI, Watson HK, Davies RJ (1989) A double-blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac®) in patients with perennial rhinitis. Allergy 44:108–115

    Article  PubMed  CAS  Google Scholar 

  14. Aas K (1971) Hyposensitization in house dust allergy asthma. Acta Paediat Scand 60:264–268

    Article  PubMed  CAS  Google Scholar 

  15. Smith AP (1971) Hyposensitization with Dermatophagoides pteronyssinus antigen: trial in asthma induced by house dust. Br Med J 4:204–206

    Article  PubMed  CAS  Google Scholar 

  16. Assem ESK, McAllen MK (1973) Changes in challenge tests following hyposensitization with mite extract. Clin Allergy 3:161–175

    Article  PubMed  CAS  Google Scholar 

  17. Bessot JC, Moreau G, Lenz D, Parini JP, Araujo-Fontaine A, Pauli G (1975) Etude comparative d’un essai de désensibilisation en double insu aux extraits de poussières et aux extraits d’acariens. Rev Fr Allerg 15:73–80

    Google Scholar 

  18. Pauli G, Bessot JC, Bigot H, Delaume G, Hordle DA, Hirth C, Thierry R (1984) Clinical and immunological evaluation of tyrosine adsorbed Dermatophagoides pteronyssinus extract: a double blind placebo controlled trial. J Allergy Clin Immunol 74:524–535

    Article  PubMed  CAS  Google Scholar 

  19. Bousquet J, Calvayrac P, Guérin B, Hejjaoui A, Dhivert H, Hewitt B, Michel FB (1985) Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol 76:734–744

    Article  PubMed  CAS  Google Scholar 

  20. McAllen MK (1961) Bronchial sensitivity testing in asthma. Thorax 16:30–35

    Article  Google Scholar 

  21. Forgacs P, Swan AV (1968) Treatment of house dust allergy. A report from the research committee of the British Tuberculosis Association. Br Med J 3:774–777

    Article  Google Scholar 

  22. Gaddie J, Skinner C, Palmer KNV (1976) Hyposensitization with house dust mite vaccine in bronchial asthma. Br Med J 2:561–562

    Article  PubMed  CAS  Google Scholar 

  23. Newton DAG, Maberley DJ, Wilson R (1978) House dust mite hyposensitization. Br J Dis Chest 72:21–28

    Article  PubMed  CAS  Google Scholar 

  24. British Thoracic Association (1979) A trial of house dust mite extract in bronchial asthma. Br J Dis Chest 73:260–270

    Article  Google Scholar 

  25. Sotomayor H, Badier M, Vervloet D, Orehek J (1984) Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen: reversal by corticosteroids. Am Rev Respir Dis 130:56–58

    PubMed  CAS  Google Scholar 

  26. Frankland AW, Augustin R (1954) Prophylaxis of summer hay fever and asthma: controlled trial comparing crude grass-pollen extracts with isolated main protein component. Lancet i:1055–1057

    Article  Google Scholar 

  27. McAllen MK (1969) Hyposensitization in grass pollen hay fever. A double blind trial of alumn precipitated pollen extract and depot emulsion pollen extract compared with placebo injections. Acta Allergol 24:421–431

    PubMed  CAS  Google Scholar 

  28. Weyer A, Donat N, L’Heritier C, Juilliard F, Pauli G, Soufflet B, David B (1981) Grass pollen hyposensitization versus placebo therapy. I. Clinical effectiveness and methodological aspects of a pre-seasonal course of desensitization with a four-grass pollen extract. Allergy 36:309–317

    Article  PubMed  CAS  Google Scholar 

  29. Bousquet J, Hejjaoui A, Skassa-Brociek W, Guérin B, Maasch HJ, Dhivert H, Michel FB (1987) Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract. J Allergy Clin Immunol 80:591–598

    Article  PubMed  CAS  Google Scholar 

  30. Mosbech H, Dreborg S, Madsen F, Ohlsson H, Skov PS, Taudorf E, Weeke B (1987) High dose grass pollen tablets used for hyposensitization in hay fever patients. Allergy 42:451–455

    Article  PubMed  CAS  Google Scholar 

  31. Van Niekerk CH, De Wet JI (1987) Efficacy of grass-maize pollen oral immunotherapy in patients with seasonal hay fever: a double-blind study. Clin Allergy 17:507–513

    Article  PubMed  Google Scholar 

  32. Lowell FC, Franklin W (1965) A double-blind study of the effectiveness and specificity of injection therapy in ragweed hay fever. N Engl J Med 273:675–679

    Article  PubMed  CAS  Google Scholar 

  33. Fontana VJ, Holt LE Jr, Mainland D (1966) Effectiveness of hyposensitization therapy in ragweed hay fever in children. JAMA 195:985–992

    Article  PubMed  CAS  Google Scholar 

  34. Norman PS, Winkenwerder WL (1968) Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos. J Allergy Clin Immunol 42:93–108

    CAS  Google Scholar 

  35. Lichtenstein LM, Norman PS, Winkenwerder WL (1968) Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever. Am J Med 44:514–524

    Article  PubMed  CAS  Google Scholar 

  36. Sadan N, Rhyne MB, Mellits ED, Goldstein EO, Levy DA, Lichtenstein LM (1969) Immunotherapy of pollinosis in children: investigation of the immunologic basis of clinical improvement. N Engl J Med 280:623–627

    Article  PubMed  CAS  Google Scholar 

  37. Lichtenstein LM, Norman PS, Winkenwerder WL (1971) A single year of immunotherapy for ragweed hay fever: immunologic and clinical studies. Ann Inter Med 75:663–671

    CAS  Google Scholar 

  38. Grammer LC, Saughnessy MA, Bernhard MI, Finkle SM, Pyle HR, Silvestri L, Patterson R (1987) The safety and activity of polymerized ragweed: a double-blind, placebo-controlled trial in 81 patients with ragweed rhinitis. J Allergy Clin Immunol 80:177–183

    Article  PubMed  CAS  Google Scholar 

  39. Viander M, Koivikko A (1978) The seasonal symptoms of hyposensitized and untreated hay fever patients in relation to birch pollen counts: correlations with nasal sensitivity, prick tests and RAST. Clin Allergy 8:387–396

    Article  PubMed  CAS  Google Scholar 

  40. Möller C, Dreborg S, Lanner A, Björksten B (1986) Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study. Allergy 41:271–279

    Article  PubMed  Google Scholar 

  41. Taudorf E, Laursen LC, Lanner A, Björksten B, Dreborg S, Søborg M, Weeke B (1987) Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol 80:153–161

    Article  PubMed  CAS  Google Scholar 

  42. Pence HL, Mitchell DQ, Greely RL, Updegraff BR, Selfridge HA (1976) Immunotherapy for mountain cedar pollinosis. A double-blind controlled study. J Allergy Clin Immunol 58:39–50

    Article  PubMed  CAS  Google Scholar 

  43. Fling JA, Ruff ME, Parker WA, Whisman BA, Martin ME, Moss RB, Reid MJ (1989) Suppression of the late cutaneous response by immunotherapy. J Allergy Clin Immunol 83:101–109

    Article  PubMed  CAS  Google Scholar 

  44. Johnstone DE (1957) Study of the role of antigen dosage in the treatment of pollinosis and pollen asthma. Am J Dis Child 94:1–5

    CAS  Google Scholar 

  45. Citron KM, Frankland AW, Sinclair JD (1958) Inhalation tests of bronchial hypersensitivity in pollen asthma. Thorax 13:229–232

    Article  PubMed  CAS  Google Scholar 

  46. McAllen MK, Heaf PJD, McInroy P (1967) Depot grass-pollen injections in asthma: effect of repeated treatment on clinical response and measured bronchial sensitivity. Br Med J i:22

    Article  Google Scholar 

  47. Ortolani C, Pastorello E, Moss RB, Hsu Y, Restuccia M, Joppolo G, Miadonna A, Cornelli U, Halpern G, Zanussi C (1984) Grass-pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. J Allergy Clin Immunol 73:283–290

    Article  PubMed  CAS  Google Scholar 

  48. Bousquet J, Guérin B, Dotte A, Dhivert H, Djoukhadar F, Hewitt B, Michel FB (1985) Comparison between rush immunotherapy with a standardized allergen and an alun adjuved pyridine extracted material in grass pollen allergy. Clin Allergy 15:179–193

    Article  PubMed  CAS  Google Scholar 

  49. Reid MJ, Moss RB, Hsu Y, Kwasnicki JM, Commerford TM, Nelson BL (1986) Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. J Allergy Clin Immunol 78:590–600

    Article  PubMed  CAS  Google Scholar 

  50. Bruce CA, Norman PS, Rosenthal RR, Lichtenstein LW (1977) The role of ragweed pollen in autumnal asthma. J Allergy Clin Immunol 59:449–459

    Article  PubMed  CAS  Google Scholar 

  51. Hill DJ, Hosking CS, Shelton MJ, Turner MW (1982) Failure of hyposensitization in treatment of children with grass-pollen asthma. Br Med J ii:306–309

    Article  Google Scholar 

  52. Taylor WW, Ohman JL, Lowell FC (1978) Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of bronchial responses to cat allergen and histamine. J Allergy Clin Immunol 61:283–287

    Article  PubMed  CAS  Google Scholar 

  53. Ohman JL, Findlay SR, Leitermann KM (1984) Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro response. J Allergy Clin Immunol 74:230–239

    Article  PubMed  Google Scholar 

  54. Sundin B, Lilja G, Graff-Lonnevig V, Hedlin G, Heilborn H, Norrlind K, Pegelow KO, Løwenstein H (1986) Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma. J. Allergy Clin Immunol 77:478–487

    Article  PubMed  CAS  Google Scholar 

  55. Van Metre TE, Marsh DG, Adkinson NF, Kagey-Sobotka A, Khattignavong A, Norman PS, Rosenberg GL (1988) Immunotherapy for cat asthma. J Allergy Clin Immunol 82:1055–1068

    Article  PubMed  Google Scholar 

  56. Valovirta E, Koivikko A, Vanto T, Viander M, Ingeman L (1984) Immunotherapy in allergy to dog: a double-blind clinical study. Ann Allergy 53:85–88

    PubMed  CAS  Google Scholar 

  57. Dreborg S, Agrell B, Foucard T, Kjellman NIM, Koivikko A, Nilsson S (1986) A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 41:131–140

    Article  PubMed  CAS  Google Scholar 

  58. Malling HJ, Drebord S, Weeke B (1986) Diagnosis and immunotherapy of mould allergy. V. Clinical Efficacy and side effects of immunotherapy with Cladosporium herbarum. Allergy 41:507–519

    Article  PubMed  CAS  Google Scholar 

  59. Horst M, Hejjaoui A, Horst V, Michel FB, Bousquet J (1989) Double-blind, placebo-controlled rush immunotherapy (RIT) with a standarized Alternaria (Alt) extract. J Allergy Clin Immunol 83:204 (abstract)

    Google Scholar 

  60. Frankland AW, Howard HW, Gorill RH (1955) Autogenous bacterial vaccines in treatment of asthma. Br Med J ii:941

    Article  Google Scholar 

  61. Helander E (1959) Bacterial vaccines in treatment of bronchial asthma. Acta Allerg (Kbh) 13:47

    Google Scholar 

  62. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC (1987) Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 79:660–677

    Article  PubMed  CAS  Google Scholar 

  63. Committee on Safety of Medicines Update (1986) Desensitizing vaccines. Br Med J 293:948

    Article  Google Scholar 

  64. Vervloet D, Kharirallah E, Arnaud A, Charpin J (1980) A prospective national study of the safety of immunotherapy. Clin Allergy 10:59–64

    Article  PubMed  CAS  Google Scholar 

  65. Position Statement (1986) Personnel and equipment to treat systemic reactions caused by immunotherapy with allergenic extracts. J Allergy Clin Immunol 77:271–273

    Article  Google Scholar 

  66. A Position Statement (1988) The waiting period after allergenic skin testing and immunotherapy: addendum to the AAAI position statement on the treatment of systemic reactions caused by allergenic immunotherapy. News & Notes 3

  67. EAACI Immunotherapy Subcommittee Position Paper (1988) Allergy 43(Suppl 6):9–33

    Google Scholar 

  68. Michel FB, Herman D, Dry J, Vervloet D, Guinnepain MT, Bousquet J, Leynadier F, Pauli G, Tonnel AB, Gervais P, Grilliat JP, Perrin-Fayolle M, Charpin J (1988) Procédure de bonne pratique en allergologie. Hyposensibilisation spécifique parentérale. Rev Fr Allerg 28:348–354

    Google Scholar 

  69. WHO/IUIS Working Group Report (1989) Current status of allergen immunotherapy. Lancet i:259–261

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’immuno-allergologie, Département des Maladies Respiratoires, Hôpital de Sainte Marguerite, 270 Boulevard de Sainte Marguerite, 13009, Marseille, France

    D. Vervloet, X. van der Brempt, D. Charpin & J. Birnbaum

Authors
  1. D. Vervloet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X. van der Brempt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Charpin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Birnbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vervloet, D., van der Brempt, X., Charpin, D. et al. Immunotherapy in allergic respiratory diseases. Lung 168 (Suppl 1), 1013–1024 (1990). https://doi.org/10.1007/BF02718239

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02718239

Key words

Search

Navigation